The DAX is a stock market index consisting of the 40 major German blue-chip companies trading on the Frankfurt Stock Exchange.
Here are the top five weighted sectors:
Sector Weightings
Industrials 24.51%
Financial Services 20.33%
Technology 18.47%
Consumer Cyclical 10.27% …
Novo Nordisk, the company behind Ozempic and Wegovy, is now Europe's largest company as global demand for its drugs have soared.
However, the Danish pharmaceutical began because of more personal reasons.
In the early 1920s, Nobel laureate August Krogh and …
From everyone at MarketGauge, we hope you’ve had an enjoyable Thanksgiving weekend and that it kicks off a happy and healthy holiday season for you and the ones you love.
November closed with the distinction of being one of the …
While this is the last Daily of this week, I want to start with a quick rundown of the Economic Economic Modern Family.
As Friday is a ½ day and Black Friday, we can only guess that based on a …
I have a few central themes for 2025.
One is the ‘vanity’ trade based on the diet drugs. News today was that Biden administration is looking to expand coverage for the drugs through Medicare.
That could be reversed by Trump …
With such a great start to the holiday week, we could not help but gloat a little about the stocks I have mentioned related to the diet drugs, or what I call the “vanity” trade.
IPAR (perfumes), ELF (cosmetics) ULTA …
Last week started with the anticipation of how the market would respond to its prior week’s pullback from the enthusiastic post-election rally.
Even without a boost from NVDA’s earnings report, the stock market resumed its bull trend in some encouraging …
How long have we talked about the massive nearly 11-month price consolidation in our dear Granny Retail XRT?
What we waited for was a weekly close over 79.20, a level we have not seen since February 2022.
The Family, catching …
For hump Wednesday, I am asking the question on whether the two premier diet drug companies are finally over the hump and have stopped the bleed?
Today I read this:
WEIGHT-LOSS DRUG COVERAGE RISES AMONG LARGE US EMPLOYERS IN 2024: …
For Turnaround Tuesday, let’s reexamine the ETF XRT, which we have tracked all year.
Since February 2024, XRT has been in a massive consolidation.
While the ETF recently looked poised for a breakout and a weekly close over $80, the …